PTGX Stock | | | USD 40.58 0.67 1.62% |
Protagonist Therapeutics financial indicator trend analysis is much more than just breaking down Protagonist Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protagonist Therapeutics is a good investment. Please check the relationship between Protagonist Therapeutics Net Tangible Assets and its Cash And Short Term Investments accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in price.
For more information on how to buy Protagonist Stock please use our
How to Invest in Protagonist Therapeutics guide.
Net Tangible Assets vs Cash And Short Term Investments
Net Tangible Assets vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Protagonist Therapeutics Net Tangible Assets account and
Cash And Short Term Investments. At this time, the significance of the direction appears to have totally related.
The correlation between Protagonist Therapeutics' Net Tangible Assets and Cash And Short Term Investments is 0.99. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Protagonist Therapeutics, assuming nothing else is changed. The correlation between historical values of Protagonist Therapeutics' Net Tangible Assets and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Protagonist Therapeutics are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Net Tangible Assets i.e., Protagonist Therapeutics' Net Tangible Assets and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.99 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Protagonist Therapeutics balance sheet. This account contains Protagonist Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Protagonist Therapeutics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Protagonist Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protagonist Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in price.
For more information on how to buy Protagonist Stock please use our
How to Invest in Protagonist Therapeutics guide.
Enterprise Value is likely to rise to about 1.2
B in 2024, whereas
Selling General Administrative is likely to drop slightly above 18
M in 2024.
Protagonist Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Protagonist Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Protagonist Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to
measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.